557 related articles for article (PubMed ID: 21723781)
1. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.
Treasure T; Lang-Lazdunski L; Waller D; Bliss JM; Tan C; Entwisle J; Snee M; O'Brien M; Thomas G; Senan S; O'Byrne K; Kilburn LS; Spicer J; Landau D; Edwards J; Coombes G; Darlison L; Peto J;
Lancet Oncol; 2011 Aug; 12(8):763-72. PubMed ID: 21723781
[TBL] [Abstract][Full Text] [Related]
2. The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility study.
Treasure T; Waller D; Tan C; Entwisle J; O'Brien M; O'Byrne K; Thomas G; Snee M; Spicer J; Landau D; Lang-Lazdunski L; Bliss J; Peckitt C; Rogers S; Marriage Née Denholm E; Coombes G; Webster-Smith M; Peto J
J Thorac Oncol; 2009 Oct; 4(10):1254-8. PubMed ID: 19661833
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
4. Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.
Lim E; Waller D; Lau K; Steele J; Pope A; Ali C; Bilancia R; Keni M; Popat S; O'Brien M; Tokaca N; Maskell N; Stadon L; Fennell D; Nelson L; Edwards J; Tenconi S; Socci L; Rintoul RC; Wood K; Stone A; Muthukumar D; Ingle C; Taylor P; Cove-Smith L; Califano R; Summers Y; Tasigiannopoulos Z; Bille A; Shah R; Fuller E; Macnair A; Shamash J; Mansy T; Milton R; Koh P; Ionescu AA; Treece S; Roy A; Middleton G; Kirk A; Harris RA; Ashton K; Warnes B; Bridgeman E; Joyce K; Mills N; Elliott D; Farrar N; Stokes E; Hughes V; Nicholson AG; Rogers CA;
Lancet Respir Med; 2024 Jun; 12(6):457-466. PubMed ID: 38740044
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
[TBL] [Abstract][Full Text] [Related]
6. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.
Bölükbas S; Eberlein M; Fisseler-Eckhoff A; Schirren J
Lung Cancer; 2013 Aug; 81(2):241-6. PubMed ID: 23688589
[TBL] [Abstract][Full Text] [Related]
7. Radical multimodality therapy for malignant pleural mesothelioma.
Abdel-Rahman O; Elsayed Z; Mohamed H; Eltobgy M
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012605. PubMed ID: 29309720
[TBL] [Abstract][Full Text] [Related]
8. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.
Clive AO; Taylor H; Dobson L; Wilson P; de Winton E; Panakis N; Pepperell J; Howell T; Stewart SA; Penz E; Jordan N; Morley AJ; Zahan-Evans N; Smith S; Batchelor TJP; Marchbank A; Bishop L; Ionescu AA; Bayne M; Cooper S; Kerry A; Jenkins P; Toy E; Vigneswaran V; Gildersleve J; Ahmed M; McDonald F; Button M; Lewanski C; Comins C; Dakshinamoorthy M; Lee YCG; Rahman NM; Maskell NA
Lancet Oncol; 2016 Aug; 17(8):1094-1104. PubMed ID: 27345639
[TBL] [Abstract][Full Text] [Related]
10. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
Cao C; Tian D; Park J; Allan J; Pataky KA; Yan TD
Lung Cancer; 2014 Feb; 83(2):240-5. PubMed ID: 24360321
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
13. Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study.
Spaggiari L; Marulli G; Bovolato P; Alloisio M; Pagan V; Oliaro A; Ratto GB; Facciolo F; Sacco R; Brambilla D; Maisonneuve P; Mucilli F; Alessandrini G; Leoncini G; Ruffini E; Fontana P; Infante M; Pariscenti GL; Casiraghi M; Rea F
Ann Thorac Surg; 2014 Jun; 97(6):1859-65. PubMed ID: 24726598
[TBL] [Abstract][Full Text] [Related]
14. Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.
Cho BCJ; Donahoe L; Bradbury PA; Leighl N; Keshavjee S; Hope A; Pal P; Cabanero M; Czarnecka K; McRae K; Tsao MS; de Perrot M
Lancet Oncol; 2021 Feb; 22(2):190-197. PubMed ID: 33450184
[TBL] [Abstract][Full Text] [Related]
15. Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions.
Lauk O; Hoda MA; de Perrot M; Friess M; Klikovits T; Klepetko W; Keshavjee S; Weder W; Opitz I
Ann Thorac Surg; 2014 Nov; 98(5):1748-54. PubMed ID: 25110339
[TBL] [Abstract][Full Text] [Related]
16. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
[TBL] [Abstract][Full Text] [Related]
17. Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients.
Kostron A; Friess M; Inci I; Hillinger S; Schneiter D; Gelpke H; Stahel R; Seifert B; Weder W; Opitz I
Interact Cardiovasc Thorac Surg; 2017 May; 24(5):740-746. PubMed ID: 28453802
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
Nakas A; von Meyenfeldt E; Lau K; Muller S; Waller D
Eur J Cardiothorac Surg; 2012 May; 41(5):1031-6. PubMed ID: 22219469
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
Krug LM; Pass HI; Rusch VW; Kindler HL; Sugarbaker DJ; Rosenzweig KE; Flores R; Friedberg JS; Pisters K; Monberg M; Obasaju CK; Vogelzang NJ
J Clin Oncol; 2009 Jun; 27(18):3007-13. PubMed ID: 19364962
[TBL] [Abstract][Full Text] [Related]
20. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
